Suppr超能文献

循环炎症标志物与卒中后复发性血管事件的关系:一项前瞻性队列研究。

Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.

机构信息

Department of Clinical Neurosciences, Western General Hospital, Edinburgh, EH4 2XU, UK.

出版信息

Stroke. 2011 Jan;42(1):10-6. doi: 10.1161/STROKEAHA.110.588954. Epub 2010 Dec 2.

Abstract

BACKGROUND AND PURPOSE

inflammatory markers may be associated with recurrent vascular events after stroke. We aimed to determine the association between IL-6, C-reactive protein, fibrinogen and white cell count, with recurrent vascular events after stroke, and to compare the association between circulating inflammatory markers with the risk of death from vascular vs nonvascular causes.

METHODS

we prospectively recruited patients with acute stroke (n=817) and followed them for up to 4 years for the occurrence of fatal or nonfatal recurrent stroke, myocardial infarction or fatal vascular events, and death from any cause (n=159).

RESULTS

the delay to assessment was a median of 10 days. The adjusted incidence of the outcome cluster recurrent stroke, myocardial infarction or vascular death after stroke was significantly higher with higher levels of IL-6 (75(th) to 25(th) percentile hazard ratio, 1.56; 95% CI, 1.37-1.77), C-reactive protein (75(th) to 25(th) percentile hazard ratio, 1.08; 95% CI, 1.04-1.11), and fibrinogen (75(th) to 25(th) percentile hazard ratio, 1.45; 95% CI, 1.24-1.72). The associations between inflammatory markers and death were stronger than with recurrent vascular events. The associations of inflammatory markers with vascular and nonvascular deaths were similar.

CONCLUSIONS

although inflammatory markers were associated with an increased risk of recurrent vascular events and vascular death after stroke, they were also associated with nonvascular causes of death, suggesting that inflammatory markers do not play a causal role specifically in the generation of recurrent vascular events after stroke. Future studies of the prediction of recurrent vascular events after stroke should concentrate on clinical variables or different blood markers.

摘要

背景与目的

炎症标志物可能与卒中后复发性血管事件有关。我们旨在确定白细胞介素-6(IL-6)、C 反应蛋白(CRP)、纤维蛋白原和白细胞计数与卒中后复发性血管事件之间的关系,并比较循环炎症标志物与血管性和非血管性死亡风险之间的关系。

方法

我们前瞻性招募了急性卒中患者(n=817),并在 4 年内对其进行随访,以确定致命或非致命性复发性卒中、心肌梗死或致命性血管事件以及任何原因所致死亡(n=159)的发生情况。

结果

评估的延迟中位数为 10 天。IL-6(第 75 百分位数至第 25 百分位数的危险比为 1.56;95%可信区间为 1.37-1.77)、CRP(第 75 百分位数至第 25 百分位数的危险比为 1.08;95%可信区间为 1.04-1.11)和纤维蛋白原(第 75 百分位数至第 25 百分位数的危险比为 1.45;95%可信区间为 1.24-1.72)水平较高的患者发生卒中后复发性卒中、心肌梗死或血管性死亡的综合结局集群的校正发病率显著较高。炎症标志物与死亡的关联强于与复发性血管事件的关联。炎症标志物与血管性和非血管性死亡的关联相似。

结论

尽管炎症标志物与卒中后复发性血管事件和血管性死亡的风险增加有关,但它们也与非血管性死亡原因有关,这表明炎症标志物在卒中后复发性血管事件的发生中并非起因果作用。未来对卒中后复发性血管事件的预测研究应集中于临床变量或不同的血液标志物。

相似文献

1
Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.
Stroke. 2011 Jan;42(1):10-6. doi: 10.1161/STROKEAHA.110.588954. Epub 2010 Dec 2.
2
3
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.
PLoS Med. 2009 Sep;6(9):e1000145. doi: 10.1371/journal.pmed.1000145. Epub 2009 Sep 8.
4
Elevated inflammatory markers predict mortality in long-term ischemic stroke-survivors: a population-based prospective study.
Aging Clin Exp Res. 2017 Jun;29(3):379-385. doi: 10.1007/s40520-016-0575-9. Epub 2016 May 4.
6
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
Am Heart J. 2015 Dec;170(6):1151-60. doi: 10.1016/j.ahj.2015.09.018. Epub 2015 Oct 3.
7
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.
8
hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
J Am Heart Assoc. 2019 Jun 4;8(11):e012638. doi: 10.1161/JAHA.119.012638. Epub 2019 May 29.

引用本文的文献

1
The Role of Fibrinogen in Mediating NGAL-Associated Neuronal Damage in Acute Ischemic Stroke: A Moderated Mediation Analysis.
J Inflamm Res. 2024 Dec 6;17:10557-10570. doi: 10.2147/JIR.S495788. eCollection 2024.
3
Releasing Dynamic of Serum ST2 and Calprotectin in Patients with Acute Ischemic Stroke.
Diagnostics (Basel). 2024 Jun 23;14(13):1331. doi: 10.3390/diagnostics14131331.
5
Association of DNA methylation/demethylation with the functional outcome of stroke in a hyperinflammatory state.
Neural Regen Res. 2024 Oct 1;19(10):2229-2239. doi: 10.4103/1673-5374.392890. Epub 2024 Jan 8.
7
Fibrinogen-to-Albumin Ratio and Clinical Outcomes in Patients With Large Artery Atherosclerosis Stroke.
J Am Heart Assoc. 2023 Dec 19;12(24):e030837. doi: 10.1161/JAHA.123.030837. Epub 2023 Dec 8.
8
Predicting acute pulmonary embolism in COVID-19.
Medicine (Baltimore). 2023 Aug 25;102(34):e34916. doi: 10.1097/MD.0000000000034916.
9
Circulating Leukocyte as an Inflammatory Biomarker: Association with Fibrinogen and Neuronal Damage in Acute Ischemic Stroke.
J Inflamm Res. 2023 Mar 21;16:1213-1226. doi: 10.2147/JIR.S399021. eCollection 2023.
10
Integrated Microarray Analysis to Identify Genes and Small-Molecule Drugs Associated with Stroke Progression.
Evid Based Complement Alternat Med. 2022 Sep 1;2022:7634509. doi: 10.1155/2022/7634509. eCollection 2022.

本文引用的文献

1
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.
PLoS Med. 2009 Sep;6(9):e1000145. doi: 10.1371/journal.pmed.1000145. Epub 2009 Sep 8.
3
The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.
Atherosclerosis. 2010 Apr;209(2):551-7. doi: 10.1016/j.atherosclerosis.2009.09.030. Epub 2009 Sep 27.
4
Prognosis and prognostic research: Developing a prognostic model.
BMJ. 2009 Mar 31;338:b604. doi: 10.1136/bmj.b604.
5
Genetically elevated C-reactive protein and ischemic vascular disease.
N Engl J Med. 2008 Oct 30;359(18):1897-908. doi: 10.1056/NEJMoa0707402.
6
Associations of proinflammatory cytokines with the risk of recurrent stroke.
Stroke. 2008 Aug;39(8):2226-30. doi: 10.1161/STROKEAHA.107.504498. Epub 2008 Jun 19.
8
Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Acta Neurol Scand. 2008 Jun;117(6):415-20. doi: 10.1111/j.1600-0404.2007.00971.x. Epub 2007 Dec 18.
10
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
Arch Intern Med. 2006 Oct 23;166(19):2073-80. doi: 10.1001/archinte.166.19.2073.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验